Rate this post

Hansa Medical is a biopharmaceutical company focused on immunomodulatory enzymes for treatment and avoidance of unusual as well as serious autoimmune problems as well as transplant being rejected. Our central asset, drug candidate imlifidase, is currently in late stage medical advancement with prospective in a number of indications.

We have an ongoing discussion with prospective cooperation partners pertaining to co-development as well as co-marketing possibilities for our existing projects.
We continuously seek novel possibilities to broaden our growth pipeline in scientific or therapeutic areas connected to our existing emphasis.

For more details about our company and how to partner with us, please contact our company advancement team.


Vänligen ange din kommentar!
Vänligen ange ditt namn här